SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-218027
Filing Date
2022-08-11
Accepted
2022-08-11 08:12:45
Documents
6
Effectiveness Date
2022-08-11

Document Format Files

Seq Description Document Type Size
1 S-8 d280171ds8.htm S-8 29217
2 EX-5.1 d280171dex51.htm EX-5.1 8085
3 EX-23.1 d280171dex231.htm EX-23.1 1439
4 EX-FILING FEES d280171dexfilingfees.htm EX-FILING FEES 14029
5 GRAPHIC g280171g0810041158609.jpg GRAPHIC 14265
6 GRAPHIC g280171g0810041158852.jpg GRAPHIC 5171
  Complete submission text file 0001193125-22-218027.txt   80818
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-266761 | Film No.: 221153793
SIC: 2834 Pharmaceutical Preparations